Unknown

Dataset Information

0

Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.


ABSTRACT: Tumours develop in vertebrate organisms endowed with immune systems that are potentially able to eradicate them. Nevertheless, our ever-increasing understanding of the complex interactions between lymphocytes and tumour cells fuels the long-standing hope of developing efficient immunotherapies against cancer. This review focuses on a versatile family of proteins, the major histocompatibility complex class Ib, which has been recently implicated in both the establishment of anti-tumour immune responses and in tumour immune response evasion. We focus on a subset of class Ib proteins, human leukocyte antigen (HLA)-G, Qa-2, CD1d and NKG2D ligands, which bind to either stimulatory or inhibitory receptors expressed on T, natural killer (NK) and NKT lymphocytes, and thereby modulate their anti-tumour activity.

SUBMITTER: Gomes AQ 

PROVIDER: S-EPMC2247375 | biostudies-other | 2007 Nov

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC5091073 | biostudies-literature
| S-EPMC4228563 | biostudies-literature
| S-EPMC10442341 | biostudies-literature
| S-EPMC6665011 | biostudies-literature
| PRJNA862637 | ENA
2023-08-21 | PXD034242 | Pride
| S-EPMC9164438 | biostudies-literature
| S-EPMC3285370 | biostudies-literature
| S-EPMC17306 | biostudies-literature
| S-EPMC114676 | biostudies-literature